Ireland aligns with the EU Chips Act to grow semiconductor R&D, jobs, and advanced chip manufacturing in Europe.

There's plenty of reason to be optimistic about Synopsys' future; however, whether it could realistically make you a ...

Synopsys, Inc. (SNPS) is currently at $646.13, up $53.50 or 9.03% --Would be new all-time high (Based on available data back to Feb. 26, 1992) --Would be the first new record closing high since July 5 ...

Robust financial growth for Kiniksa Pharmaceuticals in Q2 2025, including 52% YoY ARCALYST revenue growth & raised guidance.

Incyte Corp's new chief executive, Bill Meury, outlined a growth strategy on Tuesday focused on accelerating drug development and prudent capital allocation, as the company faces the looming patent ...